Member Info for Laura2022

In June PYC out joint statement out with DosemeRx

As the company continues to develop its personalised dosing software, it will actively consider the most appropriate way to ring-fence resources for this part of its business. Options under consideration include creation of a dedicated business unit, creation of a wholly owned subsidiary or a joint venture with a party with complementary technology/ capabilities. As further progress is made towards one of these, further updates will be provided accordingly.

Dr. Peter Sargent, CEO, commented: “I’m really pleased that we’ve able to progress this initiative and the team are excited to build upon the partnership with DoseMe to further develop our Personalised Oncology Dosing Software”.

Paul Edwards, CEO, DoseMe, commented: “Oncology is one area that will benefit tremendously from precision dosing. The results from the initial research point to constructive data output that will enhance dosing decision and ultimately, make life changing differences for patients.”

Duster

In the one week of being here I've filtered 4 people

Where do these people come from !!

Good post Dysymons

These strange accounts speak with such certainty after just 3 days on LSE

They didn't say that though

They just said "interest"

Nice try

Looks like a good day ahead

Interest from several well-known companies in the oil and gas industry.

Great summary KingH

And still only £2.3mln market cap

Others in this space are £20mln+ with less revneus

The farm-out transaction is progressing well, and all parties are working diligently towards a successful conclusion. We are also pleased to report renewed and new interest from several well-known companies in the oil and gas industry. This increased interest underscores the attractiveness of PEL 94 and our strategic position in the market.

And strangely quiet

I'm still a little under water here but nearly there

Well done to Troutisout etc who were buying first time at 0.7p

Thanks flightman and hope 2025 is good for u

Fantastic

6% buyer

Presumably off a seller

Any day

A great few days here from 0.9p

Thanks Ralph

Another run to 5p possible

Last few days

I've re bought some at 2.5p

Pete S said in interview in November that the amount of data that companies now need to interpret is vast.

Hence the new biostatistics division

Continue to be in compliance with our banking covenants with sufficient liquidity headroom. Our cash balances were £6m at the end of December 2024 and net debt was £26m including a fully drawn RCF of £32m.